Political Quotes

Henry Waxman

The Public Record

Henry Waxman is a former U.S. Representative from California, serving from 1975 to 2015. A member of the Democratic Party, he was known for his work on health care, environmental policy, and consumer protection. During his tenure, Waxman played a key role in the passage of the Affordable Care Act and was a prominent advocate for climate change legislation. He chaired the House Energy and Commerce Committee, where he focused on issues such as tobacco regulation and health care reform.

Quotes by year · 1994–20222,185 total · peak 2013 (601)
1994: 19 quotes1995: 13 quotes1996: 9 quotes1997: 6 quotes1998: 18 quotes1999: 1 quote2000: 2 quotes2001: 3 quotes2002: 2 quotes2003: 3 quotes2004: 10 quotes2005: 4 quotes2006: 13 quotes2007: 13 quotes2008: 11 quotes2009: 18 quotes2010: 12 quotes2011: 574 quotes2012: 495 quotes2013: 601 quotes2014: 340 quotes2015: 2 quotes2017: 1 quote2018: 2 quotes2019: 11 quotes2021: 1 quote2022: 1 quote
Feb 7, 2012

The Political Economy Research Institute at the University of Massachusetts found that EPA's Clean Air Act cross-State air pollution rule and the mercury rule would together create nearly 1.5 million jobs over 5 years.

congress.gov
Feb 7, 2012

According to the EPA, the regulations that are subject to today's hearings will create 46,000 short-term construction jobs.

congress.gov
Feb 7, 2012

What the Republicans are giving us are false choice.

congress.gov
Feb 7, 2012

Clearly, this a Republican majority that has run out of new bad ideas, so they have just decided to recycle all of their old bad ideas.

congress.gov
Feb 7, 2012

These new standards will have tremendous health benefits.

congress.gov
Feb 7, 2012

We should be standing up for the health of infants and children, not the powerful coal and utility industries.

congress.gov
Feb 7, 2012

These new standards will cut emissions of toxic mercury by 90 percent. This is a major step forward.

congress.gov
Feb 2, 2012

Excuse me, you are going to have to use your regulatory authority to do something that should have been said in the law by Congress.

congress.gov
Feb 2, 2012

The report calls into question the adequacy of the program's performance standards.

congress.gov
Feb 2, 2012

None of us can be happy about this memo that came out last November, showing how poorly this program is serving the American public.

congress.gov
Feb 2, 2012

We didn't do our job, and that legislation needs to be revisited in light of this new information.

congress.gov
Feb 2, 2012

The challenges described in the memo are serious, and they must be addressed.

congress.gov
Feb 2, 2012

It is stunning to realize that this committee of Congress... reported legislation that simply rubber-stamped the current program for 7 additional years.

congress.gov
Feb 2, 2012

This program is intended to address the threat of terrorism to the Nation's chemical facilities.

congress.gov
Jan 31, 2012

Well, we all want these drugs on the market as fast as possible but I would be concerned about any proposal to remove FDA's ability to require clinical data when FDA thinks it is essential to assure that these drugs are safe and effective…

congress.gov
Jan 31, 2012

I agree, it is critical to retain that sunset provision so we have an opportunity to evaluate these questions, both the balance and the research questions as well.

congress.gov
Jan 31, 2012

I want to thank Representatives Mike Rogers and Anna Eshoo, who are leading the reauthorization efforts on these important laws.

congress.gov
Jan 31, 2012

Above all else, we must ensure that the prescriptions our children use are tested appropriately and deemed safe.

congress.gov
Jan 31, 2012

I believe that Americans deserve the confidence that the drugs they rely on will help them get better and not make them more sick.

congress.gov
Jan 31, 2012

When we examine claims as serious as these, we must insist on data and on facts.

congress.gov
Jan 31, 2012

I hope we would all agree that FDA should not take jobs into consideration when it is reviewing the safety and effectiveness of a new medicine.

congress.gov
Jan 31, 2012

It would be irresponsible to allow this legislation to become a vehicle for the wish lists of members seeking to move their own controversial bills.

congress.gov
Jan 31, 2012

We must reauthorize and establish these essential programs in a timely way so that FDA can do its job protecting the health and safety of American patients.

congress.gov
Jan 31, 2012

The drug and device user fee programs ensure that FDA gets critical dollars to allow the agency to complete its premarket review in a timely manner.

congress.gov

Politicians like Henry Waxman